Advertisement
Person › Details
Marcus Schindler (Novo Nordisk A/S)
Schindler, Marcus (Novo Nordisk 201801– before AstraZeneca)
Organisation | Novo Nordisk A/S | |
Group | Novo Group (Group) | |
Former/major organisation | AstraZeneca Cardiovascular and Metabolic Diseases iMed | |
Group | AstraZeneca (Group) | |
Product | pharmaceutical | |
Product 2 | drug discovery | |
Record changed: 2024-01-07 |
Advertisement
More documents for Marcus Schindler
- [1] Novo Nordisk A/S. (1/4/24). "Press Release: Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases". Bagsværd, Cambridge, MA & Somerville, MA....
- [2] Novo Nordisk A/S. (9/25/23). "Press Release: Valo Health and Novo Nordisk to Collaborate to Discover and Develop Novel Treatments for Cardiometabolic Diseases Using Human Data and Artificial Intelligence". Bagsværd & Boston, MA....
- [3] Novo Nordisk A/S. (5/10/22). "Press Release: Novo Nordisk and Flagship Pioneering Announce a Strategic Collaboration to Create a Portfolio of Transformational Medicines". Bagsværd & Cambridge, MA....
- [4] Dicerna Pharmaceuticals, Inc.. (11/18/21). "Press Release: Novo Nordisk to Acquire Dicerna". Lexington, MA....
- [5] Evotec SE. (8/18/20). "Press Release: Evotec and Novo Nordisk Form Strategic Alliance to Develop Novel Therapies for Kidney Diseases". Hamburg....
- [6] Novo Nordisk A/S. (11/18/19). "Press Release: Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-related Cardio-metabolic Diseases". Lexington, MA & Bagsværd....
- [7] Bluebird Bio, Inc.. (10/9/19). "Press Release: Bluebird Bio and Novo Nordisk Enter into Research Agreement to Develop in vivo Genome Editing Candidates for Haemophilia and Other Severe Genetic Diseases". Cambridge, MA & Bagsværd....
- [8] Novo Nordisk A/S. (12/17/18). "Press Release: Staten Biotechnology B.V. and Novo Nordisk A/S Announce Collaboration to Develop Novel Treatment for Dyslipidaemia". Nijmegen & Copenhagen....
- [9] Evotec AG. (8/22/18). "Press Release: Evotec and Novo Nordisk Form Strategic Research Alliance in Diabetes and Obesity". Hamburg....
- [10] Novo Nordisk A/S. (8/17/18). "Press Release: Novo Nordisk Acquires Ziylo Ltd to Accelerate Its Development of Glucose Responsive Insulins". Bristol & Copenhagen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top